SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Global RNAi Technologies Market to Reach $66.7 Billion by 2025: Analysis By Application, Therapeutics, Type & Geography - Research and Markets
[August 11, 2017]

Global RNAi Technologies Market to Reach $66.7 Billion by 2025: Analysis By Application, Therapeutics, Type & Geography - Research and Markets


The "Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

The Global RNAi Technologies Market is poised to grow at a CAGR of around 20.4% over the next decade to reach approximately $66.75 billion by 2025.

This industry report analyzes the global markets for RNAi Technologies across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and he future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Key Trends:


  • Rise in number of genetic and metabolic disorders
  • Improvement in synthetic delivery carriers and chemical modifications to RNA
  • Recent Technological Developments of RNAi Technologies

Companies Mentioned:

  • Alnylam Pharmaceuticals
  • Benitec Biopharma Ltd
  • Biogen Idec, Inc.
  • F. Hoffmann-La Roche Ag
  • Filmtec Corporation
  • General Electric Co.
  • Ionis Pharmaceuticals
  • Monsanto Co.
  • Nitto Denko Corp.
  • Quark Pharmaceuticals Inc.
  • Rosetta Genomics Ltd.
  • RXI Pharmaceuticals
  • SANOFI
  • Syngenta International Ag
  • Thermo Fisher Scientific, Inc

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 RNAi Technologies Market, By Application

5 RNAi Technologies Market, By Therapeutics

6 RNAi Technologies Market, By Type

7 RNAi Technologies Market, By Geography

8 Leading Companies

For more information about this report visit https://www.researchandmarkets.com/research/3lnsml/global_rnai


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy